Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment - PubMed (original) (raw)
Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment
L J Kinlen. Am J Med. 1985.
Abstract
A prospective study in the United Kingdom of 1,634 patients without transplants treated with immunosuppressive drugs (68 percent with azathioprine, 28 percent with cyclophosphamide) found an excess of non-Hodgkin's lymphoma and squamous cell skin cancer, suggesting that the excesses (although larger) of the same malignancies found among transplant recipients are not due solely to the foreign antigens of the graft. A separate analysis of the 643 patients with rheumatoid arthritis found a 13-fold increase of non-Hodgkin's lymphoma (whether treated with azathioprine or cyclophosphamide). This increase is not significantly different from the excess in similarly treated patients with other disorders in the study. In patients with rheumatoid arthritis not receiving immunosuppressive drugs, this excess is greater than that in a Finnish population and lower than that in another United Kingdom population. The findings are consistent with other evidence that immunosuppression favors the development of non-Hodgkin's lymphoma, which includes the excess of malignancies found among transplant recipients, long-term renal dialysis patients, and patients with certain primary immunodeficiency disorders. The higher risk among transplant recipients may reflect the effects of the foreign antigens, the more intensive immunosuppressive therapy, or both of these factors. In addition, the predilection for the brain, which is a well-known feature of the lymphomas after transplantation, may also apply (to a lesser extent) to other patients after immunosuppressive treatment, judging from the increasing numbers of case reports in such patients of this exceedingly rare type of malignancy. In view of the evidence of an increase of non-Hodgkin's lymphoma in rheumatoid arthritis in the absence of immunosuppressive treatment, any additional increase is likely to be small in absolute terms. Nevertheless, it needs to be weighed against the clinical benefits.
Similar articles
- Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens.
Hazleman B. Hazleman B. Am J Med. 1985 Jan 21;78(1A):39-43. doi: 10.1016/0002-9343(85)90244-x. Am J Med. 1985. PMID: 3970039 - Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.
Kinlen LJ, Sheil AG, Peto J, Doll R. Kinlen LJ, et al. Br Med J. 1979 Dec 8;2(6203):1461-6. doi: 10.1136/bmj.2.6203.1461. Br Med J. 1979. PMID: 393355 Free PMC article. - The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens.
Hazleman BL. Hazleman BL. Ann Rheum Dis. 1982;41 Suppl 1(Suppl 1):12-7. doi: 10.1136/ard.41.suppl_1.12. Ann Rheum Dis. 1982. PMID: 7039526 Free PMC article. - Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.
Jiyad Z, Olsen CM, Burke MT, Isbel NM, Green AC. Jiyad Z, et al. Am J Transplant. 2016 Dec;16(12):3490-3503. doi: 10.1111/ajt.13863. Epub 2016 Jul 7. Am J Transplant. 2016. PMID: 27163483 Review. - Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?
Bebb JR, Logan RP. Bebb JR, et al. Aliment Pharmacol Ther. 2001 Dec;15(12):1843-9. doi: 10.1046/j.1365-2036.2001.01125.x. Aliment Pharmacol Ther. 2001. PMID: 11736713 Review.
Cited by
- Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.
Arnold M, Schrieber L, Brooks P. Arnold M, et al. Drugs. 1988 Sep;36(3):340-63. doi: 10.2165/00003495-198836030-00005. Drugs. 1988. PMID: 3056693 Review. - Post-transplant malignancy: the role of immunosuppression.
Penn I. Penn I. Drug Saf. 2000 Aug;23(2):101-13. doi: 10.2165/00002018-200023020-00002. Drug Saf. 2000. PMID: 10945373 Review. - Kaposi's sarcoma of the colon in a young HIV-negative woman with Crohn's disease.
Puy-Montbrun T, Pigot F, Vuong PN, Ganansia R, Denis J. Puy-Montbrun T, et al. Dig Dis Sci. 1991 Apr;36(4):528-31. doi: 10.1007/BF01298888. Dig Dis Sci. 1991. PMID: 2007372 - Risk of lymphoma: inflammatory bowel disease and immunomodulators.
Ang YS, Farrell RJ. Ang YS, et al. Gut. 2006 Apr;55(4):580-1. Gut. 2006. PMID: 16531538 Free PMC article. No abstract available. - Risk of cancer among rheumatoid arthritis patients in California.
Parikh-Patel A, White RH, Allen M, Cress R. Parikh-Patel A, et al. Cancer Causes Control. 2009 Aug;20(6):1001-10. doi: 10.1007/s10552-009-9298-y. Epub 2009 Jan 28. Cancer Causes Control. 2009. PMID: 19184473 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical